Wang Jiahao, Hu Yulin, Han Yuemei, Fang Qiuna, Chen Zhirong, Wang Yajia, Zhao Peiyi, Wang Hui, Lin Quankui
Department of Biomaterials, National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China.
Regen Biomater. 2023 Mar 8;10:rbad020. doi: 10.1093/rb/rbad020. eCollection 2023.
Posterior capsule opacification (PCO), the most common complication after cataract surgery, is caused by the proliferation, migration and epithelial-mesenchymal transition (EMT) of residual lens epithelial cells in the capsule bag. Although the surface modification and drug loading of intraocular lens (IOLs) have been effective in preventing PCO to some extent, the intraocular safety of anti-proliferative drug application is still a major limitation in clinical application. In this study, we used non-viral gene delivery systems in combination with layer-by-layer (LBL) self-assembly technology, and the modified IOL could effectively prevent the development of PCO by interfering with the EMT process mediated by the platelet-derived growth factor receptor-α (PDGFR-α). Herein, the gene fragments were wrapped by electrostatic conjugation using polyethyleneimine-graft-poly(ethylene glycol) to form gene complexes. Gene complexes were characterized by dynamic light scattering, transmission electron microscopy (TEM) and agarose gel electrophoresis, and evaluated for storage and serum stability. The layer assembly behavior of the IOL surface, changes in optical properties and the release behavior of the gene complexes were characterized using quartz crystal microbalance, UV-vis, contact angle and TEM. experiments showed that the IOL coating has good bio-compatibility and can achieve the corresponding transfection effect, and the released gene complexes exhibited excellent cell internalization and lysosomal escape behaviors, as well as effective inhibition of PDGFR-α expression and its mediated EMT process. The early PCO prevention effect and bio-compatibility evaluation of the modified IOL were evaluated by implantation into animal eyes. This study provides a new strategy for the development of surface modifications of small nucleic acid drugs and non-toxic EMT interference therapies for PCO.
后囊膜混浊(PCO)是白内障手术后最常见的并发症,由囊袋内残留晶状体上皮细胞的增殖、迁移和上皮-间质转化(EMT)引起。尽管人工晶状体(IOL)的表面修饰和药物负载在一定程度上有效预防了PCO,但抗增殖药物应用的眼内安全性仍是临床应用中的主要限制。在本研究中,我们将非病毒基因递送系统与层层(LBL)自组装技术相结合,修饰后的IOL可通过干扰血小板衍生生长因子受体-α(PDGFR-α)介导的EMT过程有效预防PCO的发展。在此,基因片段通过聚乙烯亚胺接枝聚乙二醇进行静电共轭包裹形成基因复合物。通过动态光散射、透射电子显微镜(TEM)和琼脂糖凝胶电泳对基因复合物进行表征,并评估其储存和血清稳定性。使用石英晶体微天平、紫外可见光谱、接触角和TEM对IOL表面的层组装行为、光学性质变化和基因复合物的释放行为进行表征。实验表明,IOL涂层具有良好的生物相容性,可实现相应的转染效果,释放的基因复合物表现出优异的细胞内化和溶酶体逃逸行为,以及对PDGFR-α表达及其介导的EMT过程的有效抑制。通过植入动物眼内评估修饰后IOL的早期PCO预防效果和生物相容性。本研究为开发小核酸药物的表面修饰和无毒的PCO EMT干扰疗法提供了新策略。